Overview Dividends

(XRX) Xerox - Ratings and Ratios

Exchange: NASDAQ • Country: United States • Currency: USD • Type: Common Stock • ISIN: US98421M1062

Printers, Copiers, Software, Services, Financing

XRX EPS (Earnings per Share)

EPS Growth (3Y CAGR): -41.89%
EPS Trend (3Y Correlation): -74.3%

XRX Revenue

Revenue Growth (3Y CAGR): 0.37%
Revenue Trend (3Y Correlation): -32.4%

Description: XRX Xerox October 22, 2025

Xerox Holdings Corp. (NASDAQ:XRX) is a global workplace-technology firm that blends hardware, software, and services across two segments-Print & Other and Xerox Financial Services (XFS). Its portfolio spans entry-level A4 printers, mid-range A3 devices, ConnectKey software, production presses, Managed Print Services, IT solutions, and financing options for both direct and indirect channel customers.

Key recent metrics: FY 2023 revenue was approximately $9.3 billion, with services and solutions contributing roughly 45 % of that total and growing at a 6 % YoY rate, while traditional print hardware declined about 4 % amid corporate cost-cutting and a broader shift toward digital document workflows. The company’s operating margin improved to 6.8 % after a restructuring that emphasized recurring-revenue models, and its free-cash-flow conversion hovered near 55 %-a notable outperformance versus the average 40 % seen in the broader technology-hardware sector. Macro-level drivers include sustained enterprise spending on automation, rising interest-rate sensitivity that can affect XFS financing demand, and supply-chain pressures that favor vendors with diversified component sourcing.

For a deeper quantitative dive, the ValueRay platform offers a granular breakdown of XRX’s cash-flow trends and peer-adjusted multiples.

XRX Stock Overview

Market Cap in USD	418m
Sub-Industry	Technology Hardware, Storage & Peripherals
IPO / Inception	1977-01-03

XRX Stock Ratings

Growth Rating	-88.7%
Fundamental	38.1%
Dividend Rating	39.2%
Return 12m vs S&P 500	-67.5%
Analyst Rating	2.80 of 5

XRX Dividends

Dividend Yield 12m	14.36%
Yield on Cost 5y	3.01%
Annual Growth 5y	0.00%
Payout Consistency	83.7%
Payout Ratio	94.3%

XRX Growth Ratios

Growth Correlation 3m	-83.3%
Growth Correlation 12m	-88%
Growth Correlation 5y	-86.4%
CAGR 5y	-37.35%
CAGR/Max DD 3y (Calmar Ratio)	-0.45
CAGR/Mean DD 3y (Pain Ratio)	-1.10
Sharpe Ratio 12m	-1.46
Alpha	-94.90
Beta	1.835
Volatility	67.66%
Current Volume	5739.8k
Average Volume 20d	4473.3k
Stop Loss	2.7 (-8.8%)
Signal	-0.99

Piotroski VR‑10 (Strict, 0-10) 3.0

Net Income (-977.0m TTM) > 0 and > 6% of Revenue (6% = 396.4m TTM)

FCFTA 0.04 (>2.0%) and ΔFCFTA -2.64pp (YES ≥ +1.0pp, WARN ≥ +0.5pp)

NWC/Revenue 5.36% (prev 9.70%; Δ -4.34pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp)

CFO/TA 0.04 (>3.0%) and CFO 410.0m > Net Income -977.0m (YES >=105%, WARN >=100%)

NO Net Debt/EBITDA fails (EBITDA <= 0)

Current Ratio 1.10 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active)

Outstanding Shares last Quarter (125.8m) change vs 12m ago 1.16% (target <= -2.0% for YES)

Gross Margin 38.47% (prev 32.17%; Δ 6.31pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0)

Asset Turnover 71.85% (prev 76.58%; Δ -4.73pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0)

Interest Coverage Ratio -0.10 (EBITDA TTM -98.0m / Interest Expense TTM 119.0m) >= 6 (WARN >= 3)

Altman Z'' 0.95

(A) 0.04 = (Total Current Assets 3.75b - Total Current Liabilities 3.40b) / Total Assets 10.07b

(B) 0.25 = Retained Earnings (Balance) 2.52b / Total Assets 10.07b

(D) -0.09 = Book Value of Equity -806.0m / Total Liabilities 9.47b

Total Rating: 0.95 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D)

ValueRay F-Score (Strict, 0-100) 38.14

1. Piotroski 3.0pt = -2.0

2. FCF Yield 8.15% = 4.07

3. FCF Margin 5.36% = 1.34

4. Debt/Equity 11.91 = -2.50

5. Debt/Ebitda -40.07 = -2.50

6. ROIC - WACC (= -1.30)% = -1.63

7. RoE -91.67% = -2.50

8. Rev. Trend -32.38% = -2.43

9. EPS Trend -74.33% = -3.72

What is the price of XRX shares?

As of November 06, 2025, the stock is trading at USD 2.96 with a total of 5,739,800 shares traded.
Over the past week, the price has changed by -10.50%, over one month by -16.58%, over three months by -24.06% and over the past year by -61.34%.

Is Xerox a good stock to buy?

No, based on ValueRay´s Fundamental Analyses, Xerox (NASDAQ:XRX) is currently (November 2025) a stock to sell. It has a ValueRay Fundamental Rating of 38.14 and therefor a negative outlook according to the companies health.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of XRX is around 2.18 USD . This means that XRX is currently overvalued and has a potential downside of -26.35%.

Is XRX a buy, sell or hold?

Xerox has received a consensus analysts rating of 2.80. Therefor, it is recommend to hold XRX.

Strong Buy: 1
Buy: 0
Hold: 2
Sell: 1
Strong Sell: 1

What are the forecasts/targets for the XRX price?

Issuer	Target	Up/Down from current
Wallstreet Target Price	4.5	52%
Analysts Target Price	4.5	52%
ValueRay Target Price	2.3	-22.3%

XRX Fundamental Data Overview November 02, 2025

Market Cap USD = 417.8m (417.8m USD * 1.0 USD.USD)
P/E Forward = 2.6069
P/S = 0.0632
P/B = 0.4239
P/EG = 0.1984
Beta = 1.835
Revenue TTM = 6.61b USD
EBIT TTM = -12.0m USD
EBITDA TTM = -98.0m USD
Long Term Debt = 2.81b USD (from longTermDebt, last fiscal year)
Short Term Debt = 354.0m USD (from shortTermDebt, last quarter)
Debt = 4.41b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 3.93b USD (from netDebt column, last quarter)
Enterprise Value = 4.34b USD (417.8m + Debt 4.41b - CCE 479.0m)
Interest Coverage Ratio = -0.10 (Ebit TTM -12.0m / Interest Expense TTM 119.0m)
FCF Yield = 8.15% (FCF TTM 354.0m / Enterprise Value 4.34b)
FCF Margin = 5.36% (FCF TTM 354.0m / Revenue TTM 6.61b)
Net Margin = -14.79% (Net Income TTM -977.0m / Revenue TTM 6.61b)
Gross Margin = 38.47% ((Revenue TTM 6.61b - Cost of Revenue TTM 4.07b) / Revenue TTM)
Gross Margin QoQ = 59.82% (prev 27.98%)
Tobins Q-Ratio = 0.43 (Enterprise Value 4.34b / Total Assets 10.07b)
Interest Expense / Debt = 1.25% (Interest Expense 55.0m / Debt 4.41b)
Taxrate = -153.3% (out of range, set to none) (460.0m / -300.0m)
NOPAT = unknown (EBIT/Op.Income or Taxrate missing)
Current Ratio = 1.10 (Total Current Assets 3.75b / Total Current Liabilities 3.40b)
Debt / Equity = 11.91 (Debt 4.41b / totalStockholderEquity, last quarter 370.0m)
Debt / EBITDA = -40.07 (negative EBITDA) (Net Debt 3.93b / EBITDA -98.0m)
Debt / FCF = 11.09 (Net Debt 3.93b / FCF TTM 354.0m)
Total Stockholder Equity = 1.07b (last 4 quarters mean from totalStockholderEquity)
RoA = -9.70% (Net Income -977.0m / Total Assets 10.07b)
RoE = -91.67% (Net Income TTM -977.0m / Total Stockholder Equity 1.07b)
RoCE = -0.31% (EBIT -12.0m / Capital Employed (Equity 1.07b + L.T.Debt 2.81b))
RoIC = -0.19% (negative operating profit) (EBIT -12.0m / (Assets 10.07b - Curr.Liab 3.40b - Cash 479.0m))
WACC = 1.11% (E(417.8m)/V(4.82b) * Re(12.78%) + (debt cost/tax rate unavailable))
Discount Rate = 12.78% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -10.84%
[DCF Debug] Terminal Value 63.71% ; FCFE base≈417.2m ; Y1≈433.4m ; Y5≈496.2m
Fair Price DCF = 35.73 (DCF Value 4.50b / Shares Outstanding 125.8m; 5y FCF grow 4.06% → 3.0% )
EPS Correlation: -74.33 | EPS CAGR: -41.89% | SUE: 1.56 | # QB: 1
Revenue Correlation: -32.38 | Revenue CAGR: 0.37% | SUE: -1.62 | # QB: 0

Additional Sources for XRX Stock

News: Wall Street Journal | Benzinga | Yahoo Finance
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle